4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-21-068027
Chief Financial Officer bought 4,000 shares at $2.49 ($9,960)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Freve Jonathan Chief Financial Officer | 2021-12-03 | Purchase | +4,000 | $2.49 | $9,960 | 12,000 | D |
| Open-market purchases · 4,000 sh · avg $2.49 · $9,960 | |||||||
Loading xslF345X03/doc4.xml…